Filing Details
- Accession Number:
- 0001144204-14-017914
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-03-26 16:14:44
- Reporting Period:
- 2012-01-23
- Filing Date:
- 2014-03-26
- Accepted Time:
- 2014-03-26 16:14:44
- Original Submission Date:
- 2012-01-23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1429260 | Coronado Biosciences Inc | CNDO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
941841 | Md A Lindsay Rosenwald | C/O Coronado Biosciences, Inc. 24 New England Executive Park Burlington MA US 01803 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.001 Per Share | Acquisiton | 2012-01-23 | 2,000 | $6.95 | 2,461,001 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes shares of common stock issued on November 15, 2011 pursuant to the automatic conversion of preferred stock held by the Reporting Person.